Health, Equity, and Resilience in Girls and Women with ADHD Across the Lifespan
Official title: ADHD-Her: An Observational Research Protocol for Investigating Health, Equity, and Resilience (HER) in Girls and Women With ADHD Across the Lifespan
Run by University of Calgary · NCT07597707 · Data updated 2026-11-12
This study tests health and well-being measures in girls and women with and without ADHD across Canada to see how ADHD relates to life phases and experiences.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 10 Years and up |
| Sex | Women only |
| Enrollment | 1460 (estimated) |
| Sponsor | University of Calgary Academic / other |
| Locations | 1 site (Calgary, Alberta) |
| Status | Recruiting |
| Started | August 25, 2025 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | May 19, 2026 |
| Trial ID | NCT07597707 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals assigned female at birth or identifying as girls/women, aged 10 years or older, living in Canada, with access to the internet and able to complete surveys in English or French.
✕Probably not a fit
Participants who do not have ADHD or do not complete the survey may not directly benefit from the study findings.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a cross-sectional, online observational study enrolling people assigned female at birth or identifying as girls/women, aged 10 and older, in Canada. It collects a multi-dimensional survey on ADHD symptoms, hormonal/developmental life phases, childhood experiences, health, and psychosocial outcomes. The study aims to enroll at least 1,460 participants across five age groups, with child participants enrolled with a parent dyad; some strata may be overrecruited to account for reporting variability and developmental processes. All participation is remote and available in English and French, with data analyzed to explore associations by age, life stage, and diagnostic status.
Why it matters
Potential benefit: If successful, findings could improve understanding of how ADHD affects health and resilience across different life stages in girls and women.
How similar studies have gone: Previous observational work has explored ADHD in girls and women, but this study adds a large, life-span perspective with multi-domain health data in a Canadian population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Assigned female at birth or identify as girl or women * Fluency in English or French * Aged 10 years or older * Currently reside in Canada * Access to technology to complete study measures Exclusion Criteria: * Self-reported intellectual disability
Where it's running
-
University of Calgary
Calgary, Alberta, Canada Recruiting
Study contacts
- Principal investigator: Emma A Climie, PhD — University of Calgary
- Study coordinator: Emma A Climie, PhD
- Email: eaclimie@ucalgary.ca
- Phone: 403-220-7770
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Biomarkers that predict medication-related side effects in children with ADHD
This study tests whether combined brain, cognitive, and metabolite markers can predict side effects from methylphenidate in kids with ADHD.
-
Group CBT vs. Activity Group for Adults with ADHD
This trial tests whether group cognitive behavioral therapy helps adults with ADHD more than a structured activity group.
-
Central Executive Training and Behavioral Parent Training for Young Children with ADHD
This study tests Central Executive Training (CET) alone and CET combined with Behavioral Parent Training (BPT) to help young children with ADHD.
-
Solriamfetol for ADHD in teens: see if it helps with focus
This phase 3 study tests solriamfetol versus placebo in adolescents with ADHD to see if the medication improves symptoms over 6 weeks.
-
Solriamfetol for children with ADHD: a 6-week comparison to placebo
This trial tests whether solriamfetol can help children aged 6 to under 12 with ADHD, compared to placebo, over six weeks.
-
Impact of Sleep Timing and Duration on Teens with ADHD
This study tests how changing how long and when teens with ADHD sleep affects their attention and daily functioning.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.